Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ariyoshi

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1991
[Evaluation of cardiotoxicity in new anthracycline analog ME 2303. ME 2303 Study Group]K Okuma, Y Ariyoshi, A Wakui, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients. SDZ ILE 964 (IL-3) StudyS Kudoh, T Sawa, N Kurihara, et al.
Japanese Journal of Clinical Oncology|December 1, 1988
B-cell lymphoma of probable thymic origin: case reportT Kataoka, A Oyama, H Suzuki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of NK313 in malignant lymphomas: an NK313 Malignant Lymphoma Study Group trialT Yoshida, M Ogawa, K Ota, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1992
Phenotypic and genotypic lineage switch of a lymphoma with shared chromosome translocation and T-cell receptor gamma gene rearrangementK Yamamoto, H Osada, M Seto, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: a phase II trial of West Japan Thoracic Oncology GroupS Kudoh, S Nakamura, T Nakano, et al.
Gene Therapy|February 3, 2016
The induction of antigen-specific CTL by in situ Ad-REIC gene therapyY Ariyoshi, M Watanabe, S Eikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. BMS-181339 Non-Small Cell Lung Cancer Study Group]S Yoneda, Y Nishiwaki, H Niitani, et al.
Japanese Journal of Clinical Oncology|December 1, 1996
Combination phase I/II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin's lymphoma. CPT-11/Lymphoma Study GroupK Tobinai, T Hotta, H Saito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group]T Isobe, M Fukuoka, S Negoro, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1991
[Evaluation of cardiotoxicity in new anthracycline analog ME 2303. ME 2303 Study Group]K Okuma, Y Ariyoshi, A Wakui, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients. SDZ ILE 964 (IL-3) StudyS Kudoh, T Sawa, N Kurihara, et al.
Japanese Journal of Clinical Oncology|December 1, 1988
B-cell lymphoma of probable thymic origin: case reportT Kataoka, A Oyama, H Suzuki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of NK313 in malignant lymphomas: an NK313 Malignant Lymphoma Study Group trialT Yoshida, M Ogawa, K Ota, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1992
Phenotypic and genotypic lineage switch of a lymphoma with shared chromosome translocation and T-cell receptor gamma gene rearrangementK Yamamoto, H Osada, M Seto, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: a phase II trial of West Japan Thoracic Oncology GroupS Kudoh, S Nakamura, T Nakano, et al.
Gene Therapy|February 3, 2016
The induction of antigen-specific CTL by in situ Ad-REIC gene therapyY Ariyoshi, M Watanabe, S Eikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. BMS-181339 Non-Small Cell Lung Cancer Study Group]S Yoneda, Y Nishiwaki, H Niitani, et al.
Japanese Journal of Clinical Oncology|December 1, 1996
Combination phase I/II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin's lymphoma. CPT-11/Lymphoma Study GroupK Tobinai, T Hotta, H Saito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group]T Isobe, M Fukuoka, S Negoro, et al.
Pageof 22